BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19371401)

  • 1. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.
    Scully C; Bagan J
    Oral Dis; 2009 Sep; 15(6):388-99. PubMed ID: 19371401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary and environmental risk factors; clinical and laboratory risk matters for head and neck, especially oral, cancer and precancer.
    Johnson NW; Warnakulasuriy S; Tavassoli M
    Eur J Cancer Prev; 1996 Feb; 5(1):5-17. PubMed ID: 8664810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friend leukaemia insertion (Fli)-1 is a prediction marker candidate for radiotherapy resistant oral squamous cell carcinoma.
    Shintani S; Hamakawa H; Nakashiro K; Shirota T; Hatori M; Tanaka M; Kuroshita Y; Kurokawa Y
    Int J Oral Maxillofac Surg; 2010 Nov; 39(11):1115-9. PubMed ID: 20709497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
    Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
    Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma: new insights.
    Jordan RC; Daley T
    J Can Dent Assoc; 1997; 63(7):517-8, 521-5. PubMed ID: 9264211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma.
    Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A
    Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular aspects of oral cancer.
    Nagler RM
    Anticancer Res; 2002; 22(5):2977-80. PubMed ID: 12530028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma.
    Roychoudhury P; Chaudhuri K
    Br J Cancer; 2007 Aug; 97(4):574-5; author reply 576. PubMed ID: 17667925
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
    Ding X; Sun J; Wang L; Li G; Shen Y; Zhou X; Chen W
    Oncol Rep; 2008 Nov; 20(5):1041-5. PubMed ID: 18949399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
    Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
    Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of squamous cell carcinoma of the oral cavity in Iran.
    Andisheh-Tadbir A; Mehrabani D; Heydari ST
    J Craniofac Surg; 2008 Nov; 19(6):1699-702. PubMed ID: 19098587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
    Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
    Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelins and their receptors as biological markers for oral cancer.
    Hoffmann RR; Yurgel LS; Campos MM
    Oral Oncol; 2010 Sep; 46(9):644-7. PubMed ID: 20656542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis.
    Pal M; Chaudhuri SR; Jadav A; Banerjee S; Paul RR; Dutta PK; Ghosh B; Chatterjee J; Chaudhuri K
    Tissue Cell; 2008 Dec; 40(6):425-35. PubMed ID: 18573513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of oral cavity squamous cell carcinoma.
    Kupferman ME; Myers JN
    Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.